Anti-NF-kappaB p100 (phospho Ser872) Antibody (A94366)

Name: Anti-NF-kappaB p100 (phospho Ser872) Antibody
Brand: Antibodies.com
SKU: A94366
Price: 115.0 GBP
Availability: InStock

Enlarge Image

This product is discontinued

Anti-NF-kappaB p100 (phospho Ser872) Antibody (A94366) has been discontinued and is no longer available.

View all NFKB2 Antibodies.

Specifications

Name

Anti-NF-kappaB p100 (phospho Ser872) Antibody

Description

Rabbit polyclonal antibody to NF-kappaB p100 (phospho Ser872).

Specificity

This antibody detects endogenous levels of NF-kappaB p100 only when phosphorylated at Ser872.

Applications

WB, ELISA

Dilutions

WB: 1:500~1:1000, IHC: 1:50~1:100, ELISA: 1:10000

Reactivity

Human, Mouse

Immunogen

Synthetic peptide derived from human NF-kappaB p100 around the phosphorylation site of Ser872 (amino acids 838-887).

Host

Rabbit

Clonality

Polyclonal

Isotype

IgG

Conjugate

Unconjugated

Purification

Purified from rabbit serum by antigen affinity chromatography using the immunizing phospho peptide.

Molecular Weight

96kDa

Product Form

Liquid

Formulation

Supplied in Phosphate Buffered Saline (without Mg2+ and Ca2+), pH 7.4, with 150mM NaCl, 0.02% Sodium Azide, and 50% Glycerol.

Storage

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Synonyms

DNA-binding factor KBF2, H2TF1, Lymphocyte translocation chromosome 10 protein, Lyt10, Nuclear factor NF-kappa-B p100 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, Oncogene Lyt-10

Isotype Controls

Suitable Secondaries

See all Anti-Rabbit IgG Secondaries →

Disclaimer

This product is for research use only. It is not intended for diagnostic or therapeutic use.

Scientific Validation DataValidation Data (1)

Enlarge Image

Western Blot - Anti-NF-kappaB p100 (phospho Ser872) Antibody (A94366)

Western blot analysis of lysates from RAW264.7 cells treated with EGF 200ng/ml 30' using Anti-NF-kappaB p100 (phospho Ser872) Antibody. The right hand lane represents a negative control, where the antibody is blocked by the immunising peptide.